Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

78% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (4)
P 2 (1)
P 4 (2)

Trial Status

Completed7
Terminated2
Unknown2
Not Yet Recruiting1
Active Not Recruiting1

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
Showing all 13 trials

Research Network

Activity Timeline